
Adagene ADAG
€ 3.46
-13.45%
Geschäftsbericht 2024
hinzugefügt 21.03.2026
Adagene Finanzkreislauf 2011-2026 | ADAG
Finanzkreislauf Jährlich Adagene
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 53.8 | 125 | 182 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 182 | 53.8 | 120 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
AbbVie
ABBV
|
284 | $ 208.84 | -2.86 % | $ 369 B | ||
|
AbCellera Biologics
ABCL
|
173 | $ 3.52 | 0.28 % | $ 1.05 B | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.24 | -0.12 % | $ 6.83 B | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
ANI Pharmaceuticals
ANIP
|
235 | $ 74.21 | -2.3 % | $ 1.43 B | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
Autolus Therapeutics plc
AUTL
|
119 | $ 1.41 | 2.17 % | $ 375 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Cocrystal Pharma
COCP
|
51.2 | $ 1.51 | 48.04 % | $ 17 M | ||
|
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
BioMarin Pharmaceutical
BMRN
|
733 | $ 55.5 | -3.04 % | $ 10.6 B | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 8.03 | 2.29 % | $ 220 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
72.3 | $ 14.81 | 2.63 % | $ 2.25 B | ||
|
Altimmune
ALT
|
7.85 K | $ 3.34 | 7.05 % | $ 294 M | ||
|
Amgen
AMGN
|
217 | $ 347.94 | -1.51 % | $ 187 B | ||
|
Aurinia Pharmaceuticals
AUPH
|
612 | $ 15.61 | 0.9 % | $ 2.1 B | ||
|
Bristol-Myers Squibb Company
BMY
|
58.6 | $ 59.6 | -2.45 % | $ 121 B | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
463 | $ 9.02 | -3.84 % | $ 1.86 B | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
Cellectis S.A.
CLLS
|
-839 | $ 3.41 | 1.19 % | $ 116 M | ||
|
Biogen
BIIB
|
337 | $ 177.34 | -3.5 % | $ 26 B | ||
|
Axon Enterprise
AXON
|
86.2 | $ 412.81 | -2.54 % | $ 31.3 B |